Analyses of the frequencies of NKG2A expressing cells showed no significant differences in the CD56bright NK subset (Fig. 4A), CD56dim NK subset (Fig. 4B) nor in the CD56− NK subset among groups of HC, PD patients with UPDRS scores <20, or those with scores 20+ (Fig. 4C). This evidence concerns the gene KLRC1 and Parkinson disease.